Immune responses drive chorioretinitis and retinal pathology after neonatal CMV infection

Jessica L McCord1, John Y S Han2, Ross E Staudt1

  • 1Department of Microbiology and Immunology, Jefferson Center for Vaccines and Pandemic Preparedness, Sidney Kimmel Medical College, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

Science Advances
|November 20, 2024
PubMed

Insights

Congenital human cytomegalovirus (CMV) infection causes neurological issues. Murine CMV infection in newborn mice shows the immune system drives eye pathology, not just the virus.

Area of Science:

  • Virology
  • Immunology
  • Ophthalmology

Background:

  • Congenital human cytomegalovirus (CMV) infection is a leading cause of non-genetic sensorineural hearing loss and neurodevelopmental disability.
  • Murine cytomegalovirus (MCMV) infection in newborn mice serves as a model for congenital CMV neuropathology.
  • Current understanding suggests CMV retinitis results from virus-driven necrosis, independent of T cell responses.

Purpose of the Study:

  • To establish a murine model for congenital CMV ocular disease.
  • To investigate the role of immune responses in MCMV-induced retinal pathology.
  • To determine if T cell responses contribute to ocular disease in congenital MCMV infection.

Main Methods:

  • Infection of newborn mice with MCMV.
  • Histopathological analysis of retinal tissues.
  • Assessment of immune cell infiltration and gliosis.
  • Pharmacological blockade of immune responses, including CXCR3 inhibition.

Main Results:

  • MCMV infection in mice recapitulated key features of human congenital CMV eye disease, including chorioretinitis, vascular inflammation, and blood-retinal barrier disruption.
  • Retinal infection led to significant T cell infiltration and gliosis.
  • Blocking immune responses, particularly targeting CXCR3, ameliorated retinal pathology despite ongoing MCMV infection.

Conclusions:

  • The MCMV-infected newborn mouse is a suitable model for studying congenital retinal disease.
  • Immune responses, rather than direct viral necrosis, are the primary drivers of pathology in the neonatal eye during MCMV infection.
  • Targeting specific immune pathways may offer therapeutic strategies for congenital CMV-induced ocular disease.